1531
|
|
|
Chromosome 18 open reading frame 32 |
GPIBD25 |
|
1532
|
|
|
Chromosome 18 open reading frame 54 |
LAS2 |
|
1533
|
|
|
Chromosome 19 open reading frame 12 |
MPAN, NBIA3, NBIA4, SPG43 |
Spastic paraplegia, Breast cancer, Estrogen-receptor negative breast cancer, Global developmental delay, Hallervorden spatz syndrome, Intellectual developmental disorder, Urinary system neoplasms, Metabolic syndrome, Neurodegeneration with brain iron accumulation, Ovarian neoplasms, Ovarian serous carcinoma, Spastic ataxia, Hereditary spastic paraplegia, Diabetes mellitus type 2, Urinary bladder cancer |
1534
|
|
|
Chromosome 19 open reading frame 18 |
- |
|
1535
|
|
|
Chromosome 19 open reading frame 33 |
H2RSP, IMUP, IMUP-1, IMUP-2 |
|
1536
|
|
|
Chromosome 19 open reading frame 38 |
HIDE1 |
|
1537
|
|
|
Chromosome 19 open reading frame 67 |
- |
|
1538
|
|
|
Chromosome 19 open reading frame 73 |
- |
|
1539
|
|
|
Chromosome 19 open reading frame 81 |
- |
|
1540
|
|
|
C1D nuclear receptor corepressor |
LRP1, Rrp47, SUN-CoR, SUNCOR, hC1D |
|